Table 2

Association between diabetic medication use and a diagnosis of lung cancer
Lung cancer Control 1 Control 2 P-value
Metformin and/or TZD Any use 41.2 61.0 93.9 <0.001
>24 months 24.6 55.5 75.1 <0.001
Metformin alone Any use 25.0 30.3 49.5 <0.001
TZD alone Any use 6.5 10.5 9.9 <0.001
Insulin use 26.8 33.9 0.014
Sulfonylurea use 39.1 42.0 0.34

All numbers expressed as % of subjects taking the drugs listed in each category. Control 1 = started the defined medication prior to the diagnosis of lung cancer in the matched case, Control 2 = started the defined medication either prior to or after the diagnosis of lung cancer in the matched case.

Mazzone et al.

Mazzone et al. BMC Cancer 2012 12:410   doi:10.1186/1471-2407-12-410

Open Data